Early signaling defects in human T cells anergized by T cell presentation of autoantigen by unknown
Early Signaling Defects in Human T  Cells Anergized 
by T Cell Presentation  of Autoantigen 
By Janine M. LaSalle, Paul J. Tolentino, Gordon J. Freeman,* 
Lee M. Nadler,* and David A. Hailer 
From the Center  for Neurologic Eh'seases, Brigham and Women's Hospital; *Division of Tumor 
Immunology, Dana Farber Cancer Institute; and Harvard Medical School, Boston, Massachusetts 
02115 
Summary 
Major histocompatibility complex class II-positive human T cell clones are nontraditional antigen- 
presenting cells (APCs) that are able to simultaneously  present and respond to peptide or degraded 
antigen, but are unable to process intact protein. Although T cell presentation of peptide antigen 
resulted in a primary proliferative  response,  T  cells that had been previously stimulated by T 
cells presenting antigen were completely unresponsive to antigen but not to interleukin 2 (I1.-2). 
In contrast, peptide antigen presented by B cells or DR2 + L cell transfectants resulted in T cell 
activation and responsiveness  to restimulation. The anergy induced by T  cell presentation of 
peptide could not be prevented by the addition of either autologous or allogeneic  B cells or 
B7+DR2 + L  cell transfectants,  suggesting that the induction of anergy could occur in the 
presence of costimulation. T cell anergy was induced within 24 h of T cell presentation of antigen 
and was long lasting. Anergized T cells expressed normal levels of T cell receptor/CD3 but were 
defective in their ability to release [Ca2+]i to both c~CD3 and APCs. Moreover,  anergized T 
cells did not proliferate to cr  monoclonal antibodies or c~CD3 plus phorbol myristate acetate 
(PMA), nor did they synthesize IL-2, II.-4, or interferon 3/mRNA in response to either peptide 
or peptide plus PMA. In contrast, ionomycin plus PMA induced both normal proliferative responses 
and synthesis of cytokine mRNA, suggesting that the signaling defect in anergized cells occurs 
before protein kinase C  activation and [Ca2+]i release. 
D 
espite the appeal of the discoveries  in recent years showing 
that autoreactive T cells are deleted in the thymus (1-4), 
such a mechanism cannot completely account for the ability 
of the immune system to avoid reactivity to self. Autoreac- 
rive T cells can be isolated from the periphery from individ- 
uals both with and without incidence of tissue-specific au- 
toimmune disease, suggesting that self-reactive T cells may 
exist without pathologic consequence in the periphery (5). 
One could argue that in most instances autoreactive T cells 
in the periphery of normal individuals would not normally 
be exposed to self-antigen presented in the context of the 
appropriate APC and would therefore be harmless. However, 
a more cautiously evolved immune system would have evolved 
several "fail-safe"  mechanisms to distinguish self from for- 
eign in order to prevent autoimmunity. 
There have been many studies showing the phenomena 
of peripheral tolerance, but as yet the molecular mechanisms 
of these phenomena are unknown. Several systems have shown 
antigen-specific induction of unresponsiveness by the presence 
of antigen in an atypical form (6-8).  High-dose tolerance, 
in which T cells exposed to a supraoptimum concentration 
of antigen are less responsive than at lower concentrations, 
has been speculated to be due to repeated antigenic stimula- 
tion of the T cells by Ia-peptide complexes (9). Lamb et al. 
(10) developed a system of unresponsiveness similar to high- 
dose tolerance in which human T cell clones pretreated with 
their cognate peptide in the absence of APCs were rendered 
unresponsive to antigen upon subsequent stimulation. Both 
the appropriate MHC molecule and the appropriate peptide 
antigen were required to create this state of antigen-induced 
antigen-specific tolerance (11). 
Antigen presented by splenocytes that have been chemi- 
caUy crosslinked by 1-ethyl-3-(dimethylaminopropyl)carbodii- 
mide (ECDI) can also induce a state of T cell unresponsive- 
ness to that antigen in vivo (12). Schwartz and colleagues 
(6-8) have investigated this phenomenon extensively in vitro 
and  have  hypothesized that  antigen unresponsiveness,  or 
anergy,  results from inappropriate antigen presentation in 
which a T cell received a signal through its TCK/CD3 com- 
plex without receiving a second costimulation. Support for 
this model has come from other in vitro systems that use 
immobilized o~ CD3 to anergize T cell clones (13). The liga- 
tion of CD28 on T cells by c~CD28 mAb or its natural ligand, 
B7, expressed on accessory cells appears to provide costimu- 
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has been speculated to be involved in the prevention of anergy 
by traditional APCs, although such a mechanism has not been 
dearly demonstrated. 
Evidence for peripheral tolerance has also been observed 
in transgenic mice in which foreign MHC is expressed only 
in tissue-specific cells in the periphery (17-19). In these mice, 
T cells reactive with this antigen are not deleted but are un- 
responsive to stimulation through the TCR. A similar TCR 
unresponsiveness has been seen in peripheral T cells from trans- 
genic mice and bone marrow chimeric mice, which have in- 
complete deletion of autoreactive T cells (20,  21). In an ex- 
ample  of a  potentially different mechanism of peripheral 
tolerance in vivo, mature autoreactive T cells are first expanded 
and then eliminated in the periphery after exposure to an- 
tigen (19). Although studies can be performed to characterize 
the state of anergy in terms of signaling pathways on aner- 
gized T cells isolated from these in vivo situations, it is difficult 
to study the mechanism that induces anergy. 
Here we show a system of T cell anergy in human T cells 
that results from stimulation by peptide antigen presented 
by T cells as opposed to traditional APCs (22). The addition 
of antigen presenting and nonpresenting accessory cells does 
not prevent the induction of unresponsiveness by T cells pre- 
senting antigen, suggesting that anergy results from a domi- 
nant negative signal rather than the lack of positive costimu- 
lation, as has been suggested in other systems (6-8). The block 
in signaling of anergized T cells appears to be before the re- 
lease of [Ca2+]i,  as anergized T  cells fail to release [Ca2+]i 
in response to antigenic stimulation, but can be stimulated 
to proliferate by the combination of Ca  2  § ionophore and the 
phorbol ester PMA. These results may provide a mechanism 
to explain one model of T cell tolerance in which free pep- 
tide antigen induces tolerance in responding T  cell clones. 
Materials and Methods 
Generation of MBP-reactive T Cell Clones.  Myelin basic protein 
(MBP)l-reactive T cell lines and clones were generated as described 
previously (5).  T  call clones were generated  from  MBP  84- 
102-reactive T cell lines by limiting dilution (0.3 cells/well) in 96- 
well V-bottomed microtiter phtes (Costar, Cambridge, MA) in the 
presence of I/~g/ml PHA.P (WeUcome  Diagnostics, Beckenham, 
UK) and 10  s irradiated allogeneic PBMC in media consisting of 
ILPMI 1640 (Whittaker, Walkersville, MD),  10% pooled human 
AB serum (PHS) (Bioce11, Carson City, CA), 4 mM glutamine 
(Gibco Laboratories, Grand Island, NY),  10 mM Hepes (Whit- 
taker), 100 U/ml penicillin/streptomycin  (Gibeo Laboratories), 5% 
IL-2 (Human T stim; Collaborative Research, Bedford, MA), and 
1 U/ml rIL-4 (kindly supplied by Genetics Institute, Cambridge, 
MA). Clones were restimulated every 8-12 d at 104/well in 96- 
well round-bottomed microtiter plates (Costar) with alternating 
rounds of 40/~M 84-102-pulsed, irradiated autologous PBMC and 
PHA/altogeneic PBMC. For the experiments shown here, T cell 
clones were restimulated from aliquots of the same freeze to pre- 
vent drift from long term culture. T cells were frozen in 90% 
FCS/10%  DMSO in liquid nitrogen. 
1  Abbreviations used in this ~per: MBP, myelin  basic protein; PKC, pro- 
tein kinase C. 
MBP Peptide 84-102.  MBP peptide 84-102, amino acid sequence 
DENPVVHFFKNIVTPKTPP, was synthesized  by the solid phase 
method (Biosearch Lab, Inc., San Raphael, CA) and purified on 
HPLC as previously reported (5). 
Cell Lines.  Previously  established  EBV-transformed  B cell lines 
9010 (DK2w2, DQ1) and 9009 (DR2w21, DQ1) were grown in 
10% FCS complete  media then frozen as described  above  and thawed 
immediately  before antigen pulse. Mouse fibroblast  L cell line trans- 
fected with DK2a (kind gift of R. Sekaly,  Clinical Research Insti- 
tute, Montreal, Quebec, Canada) were grown in DMEM (Whit- 
taker), 10% FCS (Whittaker), 1.6 mM xanthine (Sigma Chemical 
Co., St. Louis, MO), 110 #M hypoxanthine (Sigma  Chemical Co.), 
18/xM mycophenolic acid (Gibco laboratories) selection media, 
frozen as described above, and thawed immediately before antigen 
pulse. HT-2 murine Ib2-dependent T cell  line (American  Type  Cul- 
ture Collection, Rockville, MD) was grown in 10% FCS com- 
plete media with 5% I1.-2 and used for IL-2 bioassay  2 d after the 
last feeding. 
mAbs.  mAbs  used in these studies include CD3-specific  OKT3 
and  2AD2, CD2-specific Tl12 and  Tl13 (kind  gifts  from  S. 
Schlossman, Dana Farber Cancer Institute, Boston, MA), HLA- 
DR-specific L243, HLA-DQ-specific  $3/4 (kind gifts from F. Bach, 
University of Minnesota, Minneapolis, MN), HLA-DP-specific 
B7/21  (kind gift from N. Flomenberg, Sloan-Kettering Cancer 
Center, New York, NY), CD28-reactive  9.3 (kind gift fromJ. Led- 
better,  Oncogen,  Seattle, WA),  CD45RA-reactive  2H4  (S. 
Schlossman), CD45RO-specific UCHbl  (Dakopatts, Glostrup, 
Denmark), LFA-3,  and LFA-1 (kind gifts from T. Springer, Center 
for Blood Research, Boston, MA), and CD25 Tac (kind gift of 
T. Waldman, NCI, NIH, Bethesda, MD). 
Proliferation Assay.  T cell clone (10S/well) was plated in tripli- 
cate and cocultured  with appropriate stimuli, designated  in the figure 
legends, for 72 h at 37~  90% humidity, 5% CO2, in 96-well 
flat-bottomed microtiter plates (Costar) pulsed with 2 #Ci[3H]  - 
TdK (2 Ci/mmol; New England Nuclear, Boston, MA) for the 
last 18 h of culture. APCs were prepared by pulsing B cells or 
L cells at 10  ~  cells/ml in complete media either in the presence or 
absence of 40 #M MBP 84-102 for 2 h at 37~  washing twice 
with 4~  HBSS (Whittaker), followed by irradiation with 5,000 
rad at 4~  To stimulate T cells without accessory  APCs, 2 #M 
MBP peptide 84-102, or 103 U/ml rlL-2 (Hoffman-La  Roche, Inc., 
Nutley, NJ) was added directly to the cells for the duration of the 
culture. 
Flow Cytometric Analysis of T  Cells.  A 1/100 dilution of the 
mAb ascites in PBS/2% PHS was used to coat T cells at 106/ml 
for 30 min. at 4~  Cells were washed twice with 4~  staining 
media, then stained with 1/60 FITC-conjugated goat anti-mouse 
Ig (Tago Inc., Burlingame, CA) for 30 min at 4~  Cells were 
washed twice as above, then fixed with 1% formaldehyde (J. T. 
Baker Chemical Co, Phillipsburg, NJ). Flow cytometric analysis 
was performed on an Epics C flow cytometer (Coulter Electronics, 
Hialeah, FL). 
B7 Transfection.  50 #g KpnI-linearized B7-pCDM8 construct 
was cotransfected with 5/~g of PvuI-linearized POP.F into L-tk- 
cells or into DR2 § btk- cells (previously transfected with DR2) 
by electroporation using an electroporator (250 V and 1,600 mF; 
Bethesda Research Laboratories, Gaithersburg, MD). The POP.F 
plasmid contains the herpes simplex virus thymidine kinase gene 
under the control of the SV40 promoter (23). DR2-B7 + trans- 
fectants were selected by growth in hypoxanthine/aminopterin/ 
thymidine (Sigma Chemical Co.) containing media and cloned. 
DR2+B7 + transfectants were selected and cloned in xanthine/ 
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sulfate (Gibco Laboratories).  Clones expressing  cell surface B7, as 
assayed by indirect immunofluorescence with anti-B7 mAb, were 
recloned. 
Measurement of[Ca+Z]i.  As described  previously (22),  T  ceil 
clones  (0.2-1.0  x  107/ml)  were  loaded with  2  /~g/ml  Indo-1 
(Sigma Chemical Co.) in culture media for 45 rain at 37~  Indo- 
loaded cells were diluted 1/10 with media and kept at 4~  until 
I rain before flow cytometric analysis (Coulter Electronics). Stimu- 
lator APCs were pulsed with or without 40/~M 84-102, washed 
twice, and resuspended in media at 4~  Unstimulated Indo-loaded 
T cells were analyzed for 30 s before addition of stimulus.  In the 
case of  cellular stimulators,  stimulator APCs plus loaded responders 
were analyzed for 30 s, then centrifuged for 1 min at 1,500 rpm 
to establish cell-cell contact, then resuspended  and analyzed for re- 
sponse.  Ionomycin (100/~g/ml) (Sigma  Chemical Co.) was used 
as a positive  control for Indo-1 loading. 
Detection of Cytokine mRNA by Northern Analysis.  T cell clone 
Ob.lA12.8 (10S/well in 96-well round-bottomed microtiter plates 
in Ib2/Ib4-supplemented media)  was grown in the presence  or 
absence  of 2  /xM  84-102  for  48  h.  Ceils  were  washed,  and 
resuspended  in complete media at 2  ￿  l&/ml in the presence or 
absence of either 10 ng/ml PMA and 1/xg/ml ionomycin, 2 #M 
84-102, or 2/xM 84-102  +  10 ng/ml PMA for 4 h at 37~  Total 
cellular  RNA was extracted using the RNAzol B method (TM 
Cinna Scientific, Friendswood, TX). 10/~g of total cellular RNA 
was fractionated by formaldehyde  gel electrophoresis  using 1.2% 
SeaKem ME agarose (FMC Bioproducts, Rockland, ME) and 2.2 M 
formaldehyde.  After fractionation, RNA was blotted onto Nytran 
membranes (Schleicher & Schueil,  Inc., Keene, NH) with a 10￿ 
SSC solution by capillary transfer overnight. Membranes were baked 
in a vacuum oven at 80"C for 2 h. For hybridization of cytokine 
probes,  membranes were prewashed in 0.5 x  SSC and 5% SDS at 
65"C for 2 h, then prehybridized in 50% formamide, 5 ￿  SSC and 
0.5% SDS, lx Denhardts' solution, 10% dextran sulfate, and 100 
#g/ml salmon sperm DNA (Sigma  Chemical Co.) at 42~  for 
1-2 h. Probes for IL-2, I1.-4, and IFN-'y (described  previously in 
reference  24) were labeled  to a specific activity of >10  s cpm//~g 
by random primer labeling method (Boehringer Mannheim, Mann- 
heim, Germany) and added to fresh hybridization buffer. Hybridi- 
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Figure  1.  T cells previously stimulated with free-peptide antigen are unresponsive to antigenic stimulation. T cell clone Ob.lA12.8 was stimulated 
either directly with MBP peptide 84-102 or with a DR2* B cell line (9010) or L cell transfectant pulsed with 84-102 for 2 h at 37~  and assayed 
for proliferation. Final concentration of peptide in wells of primary stimulation is indicated. As seen in A, all three stimuli resulted in equivalent 
T cell proliferation. 7 d later, T cells were washed and reassayed  for response to 84-102 (5 #g/ml) or B cells or L cells pulsed with 84-102 (100/~g/ml). 
As shown in B, T cells originally stimulated with high concentrations of 84-102 were unresponsive to any secondary antigenic stimulation. 
179  LaSalle  et al. zations were performed at 42~  for 20 hrs.  Filters  were washed 
in 0.2x  SSC/0.1%  SDS  twice for 10 min at 24~  then twice 
for 30 min at 50~  Autoradiography was performed at  -70~ 
for 1-5 d. 
Table  1.  Anergy Occurs in the Presence of B7 Accessory Cells 
Primary stimulation  Secondary stimulation 
DR2a  B7  84-102  84-102  cpm  _+  SEM 
Results 
T  Cells Previously Stimulated with Peptide Antigen Are Un- 
responsive to Antigen.  We have previously shown that MBP- 
reactive T  cell clones proliferate in response to peptide an- 
tigen in the absence of traditional APCs by presenting pep- 
tide antigen on their own MHC class II molecules to autolo-  + 
gnus T  cell clones (22).  We then examined whether T  cell 
presentation of antigen involved different signaling events in 
responding T  cell clones as compared with traditional APCs. 
As shown  in Fig.  1,  T  cell clone Ob.lA12.8  responded  as 
well to MBP  peptide  84-102  added  directly to  the culture  _ 
as compared with peptide bound to pulsed DR2 + B cell line 
or DR2-transfected  L  cells in a primary proliferation assay 
(Fig.  1 A).  However,  T  cells originally  stimulated  by free 
MBP 84-102 peptide antigen were unresponsive to antigen 
stimulation in any form when assayed 1 wk later (Fig.  1 B,  + 
open circles), while T  cells stimulated in primary cultures by 
peptide-pulsed B cells or DR2 + L cells responded normally 
to secondary stimulation  (Fig.  1 B, filled symbols). The de- 
gree of unresponsiveness  in  the  secondary stimulation  was 
inversely proportional  to the antigen concentration  and the 
proliferation  induced  in  the  primary stimulation. 
We have found MBP peptide induced unresponsiveness in 
five different T cell clones from two different individuals reac- 
tive against two different MBP peptide epitopes.  Only the 
specific peptide epitope induces T  cell unresponsiveness (data 
not  shown). 
The Addition of Costimulatory Cells Does Not Reverse Un- 
responsiveness.  We hypothesized that the induction of anergy 
was due to a negative signal rather than the lack of a costimula- 
tory signal on T  cell APCs since L cells (which presumably 
have no human costimulator molecules) did not induce anergy. 
However, L cells have been recently found to express murine 
B7 (G. Freeman, manuscript in preparation) and murine B7 
has been shown to costimulate human T cells (25). To directly 
test  the costimulatory effect of L  cells on the induction  of 
unresponsiveness,  we added DtL2-transfected L  cells to the  ~ 
culture of the T  cell clone with unbound  peptide antigen. 
To directly test the role of human B7 as a costimulator mole- 
cule,  the  human  B7  gene  was  transfected  into  DR2 +  and  "~ 
DR2-  L  cells.  As shown in Table 1,  T  cells cultured  for a 
week in 84-102 were not responsive to secondary antigenic 
stimulation, even when L cells expressing human B7 or coex- 
pressing B7 and  DR2  were added  to the  culture. 
To test if the unresponsiveness induced by peptide antigen 
was reversible by costimulator molecules other than B7, we 
added irradiated B7+B cells that were either the appropriate 
(9010) or inappropriate (9009) HLA-DR for antigen presen- 
tation to the culture of T  cell clone with MBP 84-102.  Fig. 
2  demonstrates  that  neither B  cell line was able to prevent 
the induction of anergy caused by T  cells responding to free 
peptide~  However, as shown in Fig. 1, stimulation with MHC- 
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T cell clone Ob.2F3.2  was cultured for 7 d in the presence or absence 
of 2 #M 84-102 with or without the addition of 104/well L cells (ir- 
radiated at 5,000 tad) with expression of DR2- and/or B7-transfected 
molecules. L cell lines with and without expression of DR2 were trans- 
letted with B7. Mean fluorescence intensity was 77.2 (mouse Ig-PE) and 
215.6  (B7-PE) for the DR2+B7 + line and  56.8 (mouse Ig-PE),  and 
158.6 (B7-PE) for the DR2-B7 + line. After the primary culture, T cells 
were washed and assayed for proliferation to 84-102. Anergic responses 
are highlighted in bold. 
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Figure  2.  T cell unresponsiveness  can not be prevented by the addition 
of B cells. T cell clone Ob.1A12.8 was cultured for 7 d of primary stimula- 
tion either alone or in the presence of 84-102 with the addition of either 
MHC class If-matched (9010) or -mismatched (9009) irradiated trans- 
formed B cells  at the numbers indicated, then washed and assayed  for prolifer- 
ation to either MBP 84-102 peptide (5 #g/ml) or rlL-2 (103 U/ml). T cells 
grown in the absence of peptide (circles)  were fully able to proliferate to 
the secondary antigenic stimulation,  while those grown  with peptide 
(squares) were antigen unresponsive regardless of the addition of B cells. 
Proliferation to II.-2 was equivalent in all cell populations. 
180  T Cell Presentation of Autoantigen Results in Clonal Anergy 106! 
=  ! 
_o 
F--  o3 
z  0 
o 
Secondary. Sfimulal[on 
￿9  alone 
[]  84-I02 
[]  IL-2 
0  2  6  24  72  168 
HOURS OF 84-102 PRIMARY STIMULATION 
Kinetics of T cell anergy.  T cell clone  Ob.lA12.8 was cul-  Figure  3. 
tured for 0-168 hours  in 5 #g/m184-102, washed, and assayed  for prolifer- 
ation to 84-102 or Ib2. Error bars represent SEM of cpm from triplicate 
cultures. Data from two consistent  but separate experiments have been 
pooled to represent all time points. 
matched B cell line 9010 that had been pulsed with peptide 
antigen and washed before culture did not lead to the un- 
responsiveness of the T cell clone. Although the T cell clone 
lost antigen responsiveness after exposure to peptide antigen, 
the response to IL-2 was unchanged, indicating that the un- 
responsiveness  was not due to cell death. 
Kinetics of  Anergy Induction.  To determine the kinetics of 
anergy induction, secondary T cell response to MBP 84-102 
peptide and IL-2 was assayed after a primary stimulation with 
peptide from 2 to 168 h.  A  >10-fold reduction in the re- 
sponse to antigen was induced within 24 h of MBP 84-102 
peptide culture, by which time the background proliferation 
(alone) had returned to that of resting cells. This unrespon- 
siveness was even further enhanced to >100-fold reduction 
of the response over 4 d and was maintained for the duration 
of the experiment, 7 d  (Fig.  3). 
Unresponsive T Cells Continue to Express CD3.  The un- 
responsiveness of peptide-anergized T cell clones could have 
been secondary to a loss of CD3/TCR cell surface expres- 
sion. This was not the case, as T cells rendered unresponsive 
by culture with peptide antigen had an equivalent CD3 sur- 
face expression as compared with nonanergized T cell clones 
(Fig.  4). 
Response of Anergized  T  Celt  Clone  to  Nonantigenic 
Stimuli.  To more precisely define which activation pathways 
are defective in anergized T cell clones, T cells anergized by 
peptide culture were treated with reagents that either mimic 
or bypass cell surface antigenic stimulation (Fig.  5).  Aner- 
gized T  cells failed to proliferate in response  to either the 
combination of otCD3 and PMA or the ot CD2 mitogenic 
mAbs  Tl12  and  Tl13.  In  contrast,  anergized  T  cells 
responded normally to the combination of PMA and iono- 
mycin, which bypasses the need for transmembrane signaling 
(26),  and to rlL-2,  which stimulates proliferation through 
a separate  pathway (27). 
Anergized T Cells Are Defective in Their Ability to Release 
Calcium after Antigenic Stimulation.  As we have previously 
shown that MBP-reactive T cell clones release [Ca2+]i in re- 
sponse  to peptide presented by antigen-pulsed T  cells or B 
cells (22), we tested the ability of peptide-anergized T  cells 
to respond in this assay. Anergized T  cells have a marked 
reduction in their release  of [Ca2+]i in response to either 
TCR crosslinking with otCD3 or peptide antigen presented 
by B cells (Fig.  6).  In contrast, the response to ionomycin 
in anergized T cell clones is equivalent to that of the nonaner- 
gized T  cell done. 
Anergized T Cells Fail to Produce Cytokines in Response to 
Antigen.  T cell clones either cultured alone or anergized with 
MBP peptide 84-102 for 48 h in a primary culture were stimu- 
lated in a secondary culture with either peptide, peptide  + 
PMA, or PMA  +  ionomycin, mKNA was extracted after 
4 h and the relative quantity of I1.-2, I1,4, and IFN-3, exam- 
ined by Northern blotting. Before the induction of anergy, 
T  cell clone Ob.lA12.8  synthesized IL-2, II.-4, and IFN-3, 
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Figure 4.  Anergized T  cells 
continue to express CD3. T cell 
done Ob.lA12.8 was cultured in 
the presence or absence  of 5 #g/ml 
84-102 for 4 d, washed, and ana- 
lyzed for both cell surface  pheno- 
type and  proliferative response. 
Cells were stained with control 
mAb Mslg-FITC  or OKT3-FITC 
(Coulter) for  30  rain  at  4~ 
washed  twice,  then  fixed  in 1% for- 
malin  and analyzed  by flow  cytom- 
etry. T cells  from  the same  primary 
culture were assayed  for prolifera- 
tion to B cells (9010) pulsed with 
or without 84-102, or rib2. 
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Figure  5.  Actiwtion  of  aner- 
gized T cells by various stimuli.  T 
cell done Ob.lA12.8 cultured in the 
presence or absence of 84-102 for 
7  d  was  washed  and  assayed for 
proliferation  to logarithmic titra- 
tions of o~CD3 +  PMA, Tl12  + 
T113,  PMA  +  ionomycin,  and 
rib2. Final concentration or ascites 
dilution of each reagent is expressed 
on the x-axis. PMA concentrations 
are listed below concentrations  of 
(xCD3  or ionomycin. 
mP,  NA in response to MBP 84-102 peptide or to a combina- 
tion ofPMA  +  ionomycin or peptide  +  PMA. In contrast, 
the anergized T cell clone failed to synthesize I1,2, I1,4, and 
IFN-'), mRNA in response to MBP 84-102 peptide alone or 
to the peptide in combination with PMA, while synthesizing 
significant cytokine mRNA in response to PMA +  ionomycin 
stimulation (Fig. 7 A). The results of the Northern analysis 
of I1,2 mRNA were confirmed by an 11,2 bioassay using HT-2 
cells (Fig. 7 B). Anergized T cells activated with peptide an- 
tigen in a secondary stimulation did not secrete II,2, whereas 
the nonanergized did secrete I1,2, as measured by the prolifer- 
ation of HT-2 cells. 
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Figure  6.  Anergized T cells are 
inhibited  in their ability to release 
1.2  [C#+]i  to  antigenic  stimulation. 
Ob.1A12.8 was cultured •  5/tg/ml 
84-102 for 7 d, washed, and loaded 
with 2/~g/ml Indo-1  for analysis 
of [Ca2+]i. Secondary stimulation 
by ionomycin (100 ttg/ml), aCD3 
(1/30 ascites dilution), or B cells 
(9010) pulsed  +  100 ttg/m184-102 
2.2l  was  added  to  flow cytometer at 
i 
I 
point  designated  by  arrows.  For 
APC  stimulation,  cells  were  re- 
moved from  flow cytometer and 
centrifuged for 1 min (represented 
by (filled Mrs). Percent response for 
each sample represents  percent  of 
cells above baseline  (poststimulus 
minus prestimulus). Figure  7.  Cytokine production by anergized T 
ceils. (.4) T ceil  clone Ob.gA12.8 was cultured with 
or without 84-102 for 2 d, washed, and stimulated 
with  or without  10  ng/ml  PMA  +  1 /~g/ml 
ionomycin or 5/zg/m184-102  +_ 10 ng/ml PMA 
for 4 h at 37~  Total cellular RNA was extracted 
by the RNAzol B method for Northern analysis. 
Brackets signify two different Northern blots of 
identical samples each hybridized with a ~-actin 
control  probe  in  addition  to  cytokine-specific 
probes. Size of mRNA was determined by stan- 
dards to be 0.9 kb Ib2, 1.3 kb IFN-o~,  0.7 kb I1.,4, 
and 1.8 kb B-actin. (8) Ob.lA12.8  was cultured 
for 2 d  _+  84-102, washed, and stimulated with 
84-102 or rlL-2 as a positive control. Supernatants 
were collected after 20 h of secondary culture and 
diluted 1:3 in cultures of HT-2 cells. Proliferation 
of HT-2 cells represents the presence of Ib2 in su- 
pematant of  84-102-stimulated  nonanergized  T cells 
and was maximal with the rlI:2-positive control. 
Anergy Is Induced Only in Peptide-specific T Cell Clones.  As 
the induction of anergy seemed to involve a dominant nega- 
tive signal that was not  overcome by the addition  of acces- 
sory cells,  it  was  important  to exclude  the possibility  that 
peptide binding to MHC class II may deliver a negative signal 
to T  cells.  To assess the involvement of the TCK in the in- 
duction of anergy, we compared the ability of an MBP-reactive 
T  cell  vs.  a  T  cell done,  derived  from  the  same individual 
by direct  single cell cloning,  to become anergized by MBP 
peptide  84-102.  As shown  in Table 2,  MBP-reactive T  cell 
done 2Hy.IGIL7 stimulated by peptide 84-102 was rendered 
unresponsive  to secondary stimulation  by both 84-102  and 
c~CD3  +  PMA, but not I1.-2. In contrast, the MHC-matched 
clone Hy.6 did not respond to 84-102  regardless of the pri- 
mary stimulation,  and the response to ~CD3  +  PMA was 
unchanged  by pretreatment  with  peptide. 
Discussion 
Traditional  APCs such as macrophages,  B cells,  and den- 
dritic cells constitutively express MHC  class II and are able 
to process and present protein antigen to CD4 § T  cells (28). 
Human  T  cells  that  express MHC  class  II after activation 
are able to present peptide or degraded antigen but not nor- 
mally process whole antigen, suggesting that they act as "non- 
traditional" APCs (22, 29-31). Although T  cell presentation 
of MBP  84-102  results  in  a  proliferative response in  a  pri- 
mary proliferation  assay, here we show  that T  cells stimu- 
lated with peptide antigen are unresponsive to secondary stim- 
ulation by either antigen or TCR/CD3  crosslinking, but not 
IL-2.  Moreover,  long-lasting  antigen  unresponsiveness  was 
induced with unbound peptide but not peptide-pulsed B cells 
or DR2 + L cell transfectants,  suggesting that the unrespon- 
siveness was not  merely due  to  an unresponsive  refractory 
period after prior stimulation, as has been suggested as a mech- 
anism of high-dose tolerance (9). We refer to this unrespon- 
siveness as anergy because the T  cells are unresponsive to an- 
tigenic stimulation while remaining  II.-2 responsive, which 
were the original criterion established to define the term (8). 
T  cell tolerance can be induced in vitro by chemically fixed 
APC or immobilized aCD3  mAb, where a  signal is deliv- 
ered through the TCR/CD3  complex without  a second es- 
sential costimulator signal (6-8). It has been shown that the 
CD28  molecule on T  cells,  interacting  with  B7 on B  cells 
Table  2.  Non-MBP-reactive  T  Cell Clone  from  the Same Subject Does Not Become Anergized to 84-102 
Primary stimulation 
2Hy.1G11.7  Hy.6 
Secondary 
stimulation  Alone  84-102  Alone  84-102 
Alone  168  _+  37  162  _+  35  95  +  18  102  +  21 
84-102  214,059  +  84,810  1,103  _+  797  69  +  25  74  _+  16 
IL-2  183,662  _+  1,336  117,032  _+  1,501  361,087  +  13,097  565,394  +  10,622 
Anti-CD3  +  PMA  216,481  +_  18,781  4,244  +  646  514,303  _+  36,834  444,584  _+  19,609 
MBP-reactive T cell clone 2Hy.IGll.7 and PHA-derived non-MBP-reactive T cell clone Hy.6 were cultured for 2 d in the presence or absence of 
2/~M 84-102. After primary culture,  T  cells were washed and assayed for proliferation to 84-102 (2 #M),  rlL-2  (103 u/ml),  or anti-CD3  mAb 
(OKT3) (1/100  asdtes dilution)  +  PMA (10 ng/ml).  Anergic responses are highlighted  in bold. 
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tory pathway necessary for T cell activation and postulated 
that the absence of B7 costimulation may lead to anergy 
(14-16). However, T cell anergy induced by self T cell pre- 
sentation  of MBP peptide appears to occur in the presence 
of costimulation because the addition of either B7 transfec- 
tants or EBV-transformed B cells, which express high levels 
of B7, were unable to prevent the induction of unresponsive- 
ness. Moreover, B cells that have the appropriate MHC and 
act as nontoleragenic APCs in the absence of flee antigen, 
and presumably compete for presentation of peptide antigen 
with T  cells during culture,  are not able to overcome the 
induction of unresponsiveness. These results suggest that the 
induction of anergy  by T cell presentation of peptide antigen 
results in a negative signal rather than the lack of a positive 
costimulation. These results have practical implications for 
the growth of antigen-specific T  cell lines and clones that 
should be restimulated in the absence of free peptide antigen 
to prevent the loss of antigen responsiveness. This dominant 
negative signal does not appear to be due to a signal through 
MHC class II because non-MBP-reactive T cell clones beating 
MHC class II do not become anergized by MBP peptide (Table 
2).  Further,  incubation  of  MBP-reactive  T  cell  clone 
2Hy.lGll.7 with an anti-DR mAb either alone or with sec- 
ondary crosslinking  with GAMIG did not anergize the T 
cell done (data not shown). In total,  these results demon- 
strate that anergy cannot be explained by a direct negative 
signal through MHC class II. 
The mechanism of anergy induced by T cell presentation 
of autoantigen was examined. Anergized T cells have a marked 
dimunition in their ability to release [Ca2+]i in response to 
either APCs or otCD3 mAb crosslinking. In addition, treat- 
ment with the combination of PMA and ionomycin com- 
pletely restored the proliferation  and partially restored the 
cytokine production of anergized T cells, suggesting that the 
signaling events after protein kinase C (PKC) activation and 
[Ca  2+ ]i release are not defective. The slight [Ca  2+ ]i increase 
in anergized T cells stimulated with APCs (Fig. 6) suggests 
that there may be a signal in anergized T  cells, exceeding 
proximal signaling events, that is perhaps involved  in the main- 
tenance  of anergy.  However,  this  level of [Ca2+]i  is  ap- 
parently not enough to reach the threshold needed for pro- 
liferation. 
Thus, the state of anergy as defined by alterations in signal 
transduction in our system are different from studies of in 
vitro donal anergy by Mueller et al. (32, 33) where no sig- 
naling defects were observed in membrane proximal events. 
The mechanism of T cell anergy induced by T cell presenta- 
tion of antigen appears similar to studies in the murine system 
of transient activation-induced anergy, which can be reversed 
by treatment with calcium ionophore with antigen or PMA 
(34). Similarities also exist with studies of transgenic mice 
in which autoreactive T cells that escape into the periphery 
fail to release [Ca  2+ ]i in response to TCR signaling but are 
able to proliferate in response to the combination of PMA 
and ionomycin (21). Therefore,  there appear to be at least 
two different states of functionally defined anergy. Just as 
cell transformation can occur by the alteration of one of many 
different molecules that regulate a cell's signal transduction 
pathway, the phenomenon of T cell anergy may be achieved 
by several  different mechanisms that affect different stages of 
T  cell activation, 
O'Hehir et al. (35, 36) have shown that T cell unrespon- 
siveness induced by peptide or superantigen can be character- 
ized by a decrease in the surface expression of CD3 together 
with an increase in CD25 16 h after the addition of peptide 
antigen. We also observe a moderate decrease in TCR/CD3 
expression and increase in CD25 expression at this early time 
point, presumably due to T cell activation (data not shown). 
However, we find that by 4 d, anergized T cells have equiva- 
lent cell surface density of CD3 as nonanergized T cells (Fig. 
4). This indicates that anergy cannot be explained simply as 
the reduction of cell surface TCR/CD3. 
As we have seen with the majority of human T cell clones 
derived from peripheral blood (24), T cell clone Ob.lA12.8 
appears to be a Th0 phenotype in its  ability  to  produce 
cytokines of both the Thl and Th2 subsets in response to 
mitogen stimulation (37). Anergized T cells were unable to 
synthesize I1-2, I1.4, or IFN-3~ mRNA, or secrete measur- 
able I1-2 in response to antigenic stimulation either with or 
without PMA, while the addition of both ionomycin and 
PMA generated cytokine synthesis. These results are consis- 
tent with both proliferation and Ca  2+ flux data, suggesting 
that the block in T  cell signaling is in an event preceding 
Ca  2  + mobilization.  The negative signal generated by T cells 
in the response to peptide  antigen is yet to be defined, as 
is the actual biochemical signaling event that is altered in these 
anergized T  cells. 
A major question in immunology  relates to how activated 
autoantigen-reactive T cells are regulated during an inflam- 
matory response. In previous work, we have shown that T 
cells are able to present peptide antigen and partially degraded 
native MBP, although they are unable to process and present 
highly purified MBP (22). This led us to speculate that acti- 
vated T cells in an inflammatory site, such as a demyelinating 
plaque in the brain, may be able to present fragments of MBP 
to other T  cells at the site. The demonstration that T cell 
presentation of peptide antigen leads to clonal unresponsive- 
ness suggests  that this  mechanism of tolerance may have 
evolved to prevent autoreactive T  cells in an inflammatory 
site from donally expanding to damaged self-tissue. A high 
extracellular  concentration of  degraded protein would be char- 
acteristic of self-antigen, while foreign antigen after the ini- 
tial in situ immune response would be present  at a lower 
concentration and become internalized into traditional APCs 
for processing and presentation.  In this way, inappropriate 
antigen presentation by T cells that can present but not pro- 
cess the antigen would lead to anergy instead of activation 
of the responding T cell clone in an inflammatory site where 
degraded self-antigen is available. 
In conclusion, we present evidence for a mechanism to ex- 
plain the initial observation of Lamb et al. (10, 11) that pretreat- 
ment of T cell clones with peptide antigen leads to antigen 
unresponsiveness. Anergy  is related to the expression of  MHC 
184  T Cell Presentation of Autoantigen Results in Clonal Anergy class II by activated human T cells, which are able to present 
peptide antigen to autologous T cells. Although this interac- 
tion leads to a primary stimulation of the T  cells, the are 
rendered unresponsive to subsequent stimulation within 24 h 
of peptide pretreatment. The signaling defect in anergized 
T cells is membrane proximal because peptide-treated T cell 
clones are inhibited in their ability to release [Ca  2+]i, pro- 
duce cytokines, and proliferate to antigenic stimuli, but ex- 
hibit a normal proliferative response to treatment with PMA 
and ionomycin. 
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